Literature DB >> 8673189

Intramuscular ketamine is superior to meperidine, promethazine, and chlorpromazine for pediatric emergency department sedation.

E M Petrack1, C M Marx, M S Wright.   

Abstract

OBJECTIVE: To compare ketamine hydrochloride (KET) with combined meperidine hydrochloride, promethazine hydrochloride, and chlorpromazine hydrochloride (MPC) for pediatric emergency department sedation with respect to onset, duration, and efficacy.
DESIGN: Prospective, randomized, double-blind clinical trial.
SETTING: Pediatric emergency department in an urban university hospital. PATIENTS: Convenience sample of 29 patients, 6 months to 6 years of age, requiring sedation for suturing, wound or burn debridement, or lumbar puncture. INTERVENTION: Children received intramuscular KET (4 mg/kg) with atropine sulfate (0.01 mg/kg) or MPC (meperidine hydrochloride 2 mg/kg, promethazine hydrochloride 1 mg/kg, chlorpromazine hydrochloride 1 mg/kg). Data collection included demographics, vital signs, and onset of sedation; procedural distress using the Observational Scale of Behavioral Distress; and time to recovery. The operator was questioned on satisfaction with the drug, and parents received follow-up to assess parental satisfaction.
RESULTS: Of the 29 patients enrolled in the study, 2 were excluded for protocol violation, 15 received KET, and 12 received MPC. Demographics and baseline vital signs did not differ. Although patients in the 2 groups had a similar duration of sedation (KET, 82 min vs MPC, 97 min, P = .15), patients receiving KET had more rapid onset of sedation (3 min vs 18 min, P < .01) a shorter time to discharge (85 min vs 113 min, P 0 .01) and lower Observational Scale of Behavioral Distress scores (9.9 vs 19.2, P = .003). All 15 physicians using KET would request it again vs 5 of 12 (42%) of the physicians using MPC (P < .001). No serious adverse reactions occurred. There were no differences in parental satisfaction.
CONCLUSION: Ketamine has a faster onset and results in more rapid discharge from the pediatric emergency department while providing for less patient distress during procedures. Ketamine is also associated with greater physician satisfaction than MPC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8673189     DOI: 10.1001/archpedi.1996.02170320022003

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  7 in total

1.  Intravenous ketamine plus midazolam is superior to intranasal midazolam for emergency paediatric procedural sedation.

Authors:  J P Acworth; D Purdie; R C Clark
Journal:  Emerg Med J       Date:  2001-01       Impact factor: 2.740

Review 2.  Pharmacological management of pain and anxiety during emergency procedures in children.

Authors:  R M Kennedy; J D Luhmann
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Ketamine: review of its pharmacology and its use in pediatric anesthesia.

Authors:  S A Bergman
Journal:  Anesth Prog       Date:  1999

4.  Pediatric procedural sedation and analgesia.

Authors:  James R Meredith; Kelly P O'Keefe; Sagar Galwankar
Journal:  J Emerg Trauma Shock       Date:  2008-07

5.  Procedural Sedation Outside of the Operating Room Using Ketamine in 22,645 Children: A Report From the Pediatric Sedation Research Consortium.

Authors:  Jocelyn R Grunwell; Curtis Travers; Courtney E McCracken; Patricia D Scherrer; Anne G Stormorken; Corrie E Chumpitazi; Mark G Roback; Jana A Stockwell; Pradip P Kamat
Journal:  Pediatr Crit Care Med       Date:  2016-12       Impact factor: 3.624

6.  Delayed emergence of behavioral and electrophysiological effects following juvenile ketamine exposure in mice.

Authors:  L R Nagy; R E Featherstone; C G Hahn; S J Siegel
Journal:  Transl Psychiatry       Date:  2015-09-15       Impact factor: 6.222

7.  Comparison of hemodynamic effects of sevoflurane and ketamine as basal anesthesia by a new and direct monitoring during induction in children with ventricular septal defect: A prospective, randomized research.

Authors:  Ding Han; Ya-Guang Liu; Shoudong Pan; Yi Luo; Jia Li; Chuan Ou-Yang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.